Haraf DJ - Search Results

1

Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer.

Cohen EE, Karrison TG, Kocherginsky M, Mueller J, Egan R, Huang CH, Brockstein BE, Agulnik MB, Mittal BB, Yunus F, Samant S, Raez LE, Mehra R, Kumar P, Ondrey F, Marchand P, Braegas B, Seiwert TY, Villaflor VM, Haraf DJ, Vokes EE. Cohen EE, et al. Among authors: haraf dj. J Clin Oncol. 2014 Sep 1;32(25):2735-43. doi: 10.1200/JCO.2013.54.6309. Epub 2014 Jul 21. J Clin Oncol. 2014. PMID: 25049329 Free PMC article. Clinical Trial.

2

The evolving role of systemic therapy in carcinoma of the lung.

Haraf DJ, Devine S, Ihde DC, Vokes EE. Haraf DJ, et al. Semin Oncol. 1992 Aug;19(4 Suppl 11):72-87. Semin Oncol. 1992. PMID: 1324527 Review.

3

Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.

Vokes EE, Weichselbaum RR, Mick R, McEvilly JM, Haraf DJ, Panje WR. Vokes EE, et al. Among authors: haraf dj. J Natl Cancer Inst. 1992 Jun 3;84(11):877-82. doi: 10.1093/jnci/84.11.877. J Natl Cancer Inst. 1992. PMID: 1375657 Clinical Trial.

4

Perspectives on combination chemotherapy with concomitant radiotherapy for poor-prognosis head and neck cancer.

Vokes EE, Haraf DJ, Weichselbaum RR, McEvilly JM, Sutton HG, Panje WR. Vokes EE, et al. Among authors: haraf dj. Semin Oncol. 1992 Aug;19(4 Suppl 11):47-56. Semin Oncol. 1992. PMID: 1509281

5

Concomitant chemoradiotherapy with cisplatin, 5-fluorouracil and hydroxyurea in poor-prognosis head and neck cancer.

Haraf DJ, Vokes EE, Weichselbaum RR, Panje WR. Haraf DJ, et al. Laryngoscope. 1992 Jun;102(6):630-6. doi: 10.1288/00005537-199206000-00007. Laryngoscope. 1992. PMID: 1602911

6

Neoadjuvant PFL augmented by methotrexate and piritrexim followed by concomitant chemoradiotherapy for advanced head and neck cancer: a feasible and active approach.

Vokes EE, Haraf DJ, McEvilly JM, Mick R, Kozloff MF, Goldman MD, Moran WJ, Clendeninn NJ, Collier MA, Weichselbaum RR, et al. Vokes EE, et al. Among authors: haraf dj. Ann Oncol. 1992 Jan;3(1):79-81. doi: 10.1093/oxfordjournals.annonc.a058079. Ann Oncol. 1992. PMID: 1606074 Clinical Trial.

7

Hydroxyurea with concomitant radiotherapy for locally advanced head and neck cancer.

Vokes EE, Haraf DJ, Panje WR, Schilsky RL, Weichselbaum RR. Vokes EE, et al. Among authors: haraf dj. Semin Oncol. 1992 Jun;19(3 Suppl 9):53-8. Semin Oncol. 1992. PMID: 1641658

8

Survival and analysis of failure following hydroxyurea, 5-fluorouracil and concomitant radiation therapy in poor prognosis head and neck cancer.

Haraf DJ, Vokes EE, Panje WR, Weichselbaum RR. Haraf DJ, et al. Am J Clin Oncol. 1991 Oct;14(5):419-26. doi: 10.1097/00000421-199110000-00012. Am J Clin Oncol. 1991. PMID: 1719793 Clinical Trial.

9

5-Fluorouracil, leucovorin, hydroxyurea, and escalating doses of continuous-infusion cisplatin with concomitant radiotherapy: a clinical and pharmacologic study.

Vokes EE, Moormeier JA, Ratain MJ, Egorin MJ, Haraf DJ, Mick R, Weichselbaum RR. Vokes EE, et al. Among authors: haraf dj. Cancer Chemother Pharmacol. 1992;29(3):178-84. doi: 10.1007/BF00686249. Cancer Chemother Pharmacol. 1992. PMID: 1733549 Clinical Trial.

10

The role of paclitaxel in the treatment of head and neck cancer.

Vokes EE, Haraf DJ, Stenson K, Stupp R, Malone D, Levin J, Weichselbaum RR. Vokes EE, et al. Among authors: haraf dj. Semin Oncol. 1995 Oct;22(5 Suppl 12):8-12. Semin Oncol. 1995. PMID: 7481866 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

149 results

Search Page